{"data":{"id":"us-co/c.r.s.-25-45-108","jurisdiction":"us-co","citation":"C.R.S. § 25-45-108","heading":"Effect on health-care coverage.","body":"Nothing in this section affects the mandatory health-care coverage for participation in clinical trials pursuant to section 10-16-106 (20), C.R.S.","path":["Title 25 - PUBLIC HEALTH AND ENVIRONMENT","Article 45 - Access to Treatments for Terminally Ill Patients","Part 1 - INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES"],"source_url":"https://olls.info/crs/crs2026-title-25.htm","current_through":"Colorado Revised Statutes 2026","vintage":"","retrieved_at":"2026-09-14T18:37:45Z","sha256":"92d9c265caacfd9be5e68d76004623950d7beb87844ae81adb135e52397a259a","source_id":"us-co","stale":false,"prev":"us-co/c.r.s.-25-45-107","next":"us-co/c.r.s.-25-45-201"},"notice":"GroundRules: Original legal text. Not legal advice."}